Atricure Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Atricure Inc 's ROA in the third quarter of 2026?
Atricure Inc achieved a return on average assets (ROA) of 2.21 % in its third quarter of 2026, this is above ATRC's average return on assets of -8.58%.
Atricure Inc assets over the 12 months ending in its third quarter of 2026 are valued at $673 million

Despite the company's net income deteriorating, Atricure Inc was able to improve its ROA compared to the second quarter of 2026.

However, within the Healthcare sector 194 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 2636, from total ROA ranking in the second quarter of 2026 at 3191.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	13.89 %	12.35 %	9.78 %	7.94 %	3.21 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	15	11	-5	-11	-29
Return On Assets (TTM)	2.21 %	1.62 %	-0.73 %	-1.85 %	-4.75 %
ATRC's Total Ranking	# 2636	# 3191	# 3034	# 3107	# 3175
Total Assets (TTM) in million	718	677	644	654	630
Seq. Total Assets Change	6.04 %	5.07 %	-1.56 %	3.83 %	4.61 %
Seq. Net Income Change	-54.62 %	8191.67 %	-93.85 %	-	-

ATRC's 5 Years Annual ROA >> Back to ATRC Management Effectiveness >> Compare ATRC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 61
Sector	# 195
Overall	# 1921

Return On Assets Statistics
High	Average	Low
8.89 %	-8.58 %	-21.71 %
(Jun 30 2022)		(Dec 31 2012)

News about Atricure Inc Return on Assets ROA

AtriCures European Beat Innovating Through Financial Challenges in Healthcare,

AtriCure s Innovative Leap: Navigating Financial Challenges with European CE Certification MASON, Ohio In a remarkable stride forward, AtriCure, Inc. (Nasdaq: ATRC), a trailblazing innovator in the realm of surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and postoperative pain management, has announced a significant regulatory achievement. The company has secured CE marking approval for the sale of its EnCompass clamp across European Union nations a noteworthy milestone in enhancing the treatment landscape for cardiovascular diseases across the continent.The CE marking, indicative of rigorous European health, safety, and environmental protection standards, opens the gateway for European surgeons to harness the advanced capabilities of the EnCompass clamp. This device is poised to revolutionize clinical procedures and patient outcomes, providing much-needed tools for more efficient surgical interventions.

Financial Statements
Atricure Inc 's Assets	$ 718 million	ATRC's Balance sheet
Atricure Inc 's Income	$ 4 million	Quarterly ATRC's Income Statement
ATRC's Income by Division		See ATRC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	7.94 %	-0.81 %	4.65 %	-4.79 %	-14.18 %
Total Assets in million	654	606	611	584	613
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-11	-45	-30	-46	50
Annual Return On Assets	-1.75 %	-7.38 %	-4.98 %	-7.96 %	8.19 %

ATRC's 5 Years Annual ROA >> Back to ATRC Management Effectiveness >> Compare ATRC ROA to its Competitors

More Return On Assets Ratios
ATRC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ATRC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ATRC's Competitors
Subscribers only: Roa for Atricure Inc 's Suppliers
Subscribers only: Return On Assets for ATRC's Customers

You may also want to know
ATRC's Roi	ATRC's Inventory Turnover Ratio	ATRC's Growth Rates	ATRC's Dividend Comparisons
	ATRC's Profitability Ratios	ATRC's Asset Turnover Ratio	ATRC's Dividend Growth
ATRC's Roe	ATRC's Valuation Ratios	ATRC's Financial Strength Ratios	ATRC's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Ge Healthcare Technologies Inc	5.85 %
Merit Medical Systems Inc	5.72 %
Incyte Corporation	5.48 %
Labcorp Holdings Inc	5.36 %
Sotera Health Company	5.26 %
Black Hawk Acquisition Corporation	5.19 %
Pacs Group Inc	4.87 %
Iqvia Holdings Inc	4.65 %
Teleflex Incorporated	4.54 %
Haemonetics Corporation	4.30 %
Henry Schein Inc	3.84 %
U S Physical Therapy Inc	3.47 %
Lifestance Health Group Inc	3.30 %
Conmed Corporation	3.18 %
Integer Holdings Corporation	3.04 %
Avantor Inc	2.89 %
Ligand Pharmaceuticals Incorporated	2.74 %
Innovage Holding Corp	2.04 %
Pfizer Inc	1.98 %
Jazz Pharmaceuticals Plc	1.77 %
Icu Medical Inc	1.51 %
Teva Pharmaceutical Industries Limited	1.26 %
Community Health Systems Inc	1.21 %
Biogen Inc	1.13 %

Date modified: 2026-11-06T12:57:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.